Henry Schein, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 03:29:46 2026-05-13 pm EDT			5-day change	1st Jan Change
69.33 ^USD	-0.03%		-4.19%	-8.17%

06:02pm	Ananym urges BWX Technologies to commercialize reactor design, says shares could double	RE
May. 06	UBS Adjusts Price Target on Henry Schein to $85 From $87, Maintains Neutral Rating	MT

Published on 03/09/2026 at 11:35 am EDT - Modified on 03/09/2026 at 12:35 pm EDT

S&P Capital IQ

Presenter Speech
Michael Cherny (Analysts)

Awesome. Good morning, everyone. Welcome to the latest session for the Leerink Global Healthcare Conference. I'm Mike Cherny, the healthcare tech and

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

06:02pm	Ananym urges BWX Technologies to commercialize reactor design, says shares could double	RE
May. 06	UBS Adjusts Price Target on Henry Schein to $85 From $87, Maintains Neutral Rating	MT
May. 06	Analyst recommendations: AMD, KKR, PayPal Holdings, Arista Networks, and TransDigm Group.
May. 05	Piper Sandler Cuts Price Target on Henry Schein to $91 From $99	MT
May. 05	Jefferies Adjusts Price Target on Henry Schein to $80 From $89, Maintains Hold Rating	MT
May. 05	Tranche Update on Henry Schein, Inc.'s Equity Buyback Plan announced on December 13, 2018.	CI
May. 05	Henry Schein, Inc., Q1 2026 Earnings Call, May 05, 2026
May. 05	Henry Schein, Inc. Reports Earnings Results for the First Quarter Ended March 28, 2026	CI
May. 05	Henry Schein reaffirms annual profit forecast, beats Q1 estimates on dental strength	RE
May. 05	Henry Schein Fiscal Q1 Non-GAAP Earnings, Net Sales Rise; Reaffirms 2026 Outlook	MT
May. 05	Earnings Flash (HSIC) Henry Schein, Inc. Reports Q1 Revenue $3.37B, vs. FactSet Est of $3.34B	MT
May. 05	Earnings Flash (HSIC) Henry Schein, Inc. Posts Q1 Adjusted EPS $1.32 per Share, vs. FactSet Est of $1.22	MT
May. 05	(HSIC) Henry Schein Expects Fiscal 2026 Non-GAAP EPS Range $5.23 to $5.37, vs. FactSet Est of $5.32	MT
May. 05	Henry Schein, Inc. Reaffirms Earnings Guidance for the Fiscal Year 2026	CI
Apr. 24	Morgan Stanley Adjusts Price Target on Henry Schein to $64 From $61, Maintains Underweight Rating	MT